MIG Capital
MIG Capital is a Munich-based venture capital manager that invests in early and growth-stage deeptech and life-sciences companies across German-speaking Europe through its sequential retail MIG Fonds (MIG Fonds 1 to 18), managing roughly 1.3 billion euros for private investors. It is best known as an early backer of BioNTech and has floated or sold companies including BioNTech, Immatics, BRAIN, NFON and Siltectra.
MIG Capital is a Munich venture capital firm with €1.3B AUM, 31 active companies and 12 exits.
- ·5 exits in the last 5 years · consistent DPI cadence.
- ·Average hold across 12 realized deals: 9 years.
- ·Top sector focus: Biotech (37% of portfolio).
- ·Fund cadence: ~3Y between vintages · last raise 2024.
Sector breakdown
43 companiesGeography breakdown
7 geographiesKey facts
Recent exits
MIG Capital sold German Bionic to Archimedes Partners in 2025 after 5 years.
MIG Capital sold Advanced Medical Balloons to Stryker in 2025 after 10 years.
MIG Capital sold Biocrates to Bruker Corporation in 2025 after 6 years.
MIG Capital sold Cynora to Samsung Display in 2022 after 10 years.
Coverage notes
6 funds tracked, 43 portfolio companies (31 active · 12 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund MIG Capital has raised, with its portfolio companies. Hand-checked from public filings.
MIG Fonds 18VC2024€100M3 assetsVC2024 · 2yr€100M3–
Unrealized
3 held| Company | Entry |
|---|---|
| CoreMedic MedTech · Germany | 2025 |
| NcodiN Deep Tech · France | 2025 |
| TIBEAY Biosciences Biotech · Netherlands | 2026 |
MIG Fonds 17ActiveEvergreen20227 assets1 exitsEvergreen2022 · 4yr–71
Unrealized
7 held| Company | Entry |
|---|---|
| ASTRA Therapeutics Biotech · Germany | 2025 |
| GlassPoint ClimateTech · US | 2024 |
| HawkCell MedTech · France | 2024 |
| IQM Quantum Computers Deep Tech · Finland | 2019 |
| Look Up Space Aerospace & Defence · France | 2023 |
| SciRhom Biotech · Germany | 2024 |
| TALPA Solutions Data & Analytics · Germany | 2023 |
Realized
1 exit| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| German Bionic Logistics · Germany | 2020 | 2025 | Secondary | Archimedes Partners | – |
MIG Fonds 16ActiveEvergreen2019€148M12 assets2 exitsEvergreen2019 · 7yr€148M122
Unrealized
12 held| Company | Entry |
|---|---|
| Hypros HealthTech · Germany | 2018 |
| Inbolt Deep Tech · France | 2022 |
| Innatera Deep Tech · Netherlands | 2020 |
| iOmx Therapeutics Biotech · Germany | 2021 |
| Kewazo Construction · Germany | 2018 |
| Liva Healthcare Industrials · Denmark | 2019 |
| mbiomics Biotech · Germany | 2023 |
| Mimi Hearing Technologies Industrials · Germany | 2021 |
| NeraCare MedTech · Germany | 2020 |
| November Deep Tech · Germany | 2018 |
| Temedica Industrials · Germany | 2020 |
| Zadient Technologies Deep Tech · France | 2021 |
Realized
2 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Advanced Medical Balloons MedTech · Germany | 2015 | 2025 | Trade Sale | Stryker | – |
| Biocrates Biotech · Austria | 2019 | 2025 | Trade Sale | Bruker Corporation | – |
MIG Fonds 15ActiveEvergreen20153 assets2 exitsEvergreen2015 · 11yr–32
Unrealized
3 held| Company | Entry |
|---|---|
| GWA Hygiene HealthTech · Germany | 2018 |
| Konux Mobility · Germany | 2016 |
| NavVis Deep Tech · Germany | 2014 |
MIG Fonds 8ActiveEvergreen20090 assets3 exitsEvergreen2009 · 17yr–03
MIG Fonds 5ActiveEvergreen20076 assets4 exitsEvergreen2007 · 19yr–64
Unrealized
6 held| Company | Entry |
|---|---|
| advanceCOR Biotech · Germany | 2012 |
| AFFiRiS Biotech · Austria | 2006 |
| AmSilk Biotech · Germany | 2008 |
| instrAction Deep Tech · Germany | 2008 |
| Isarna Therapeutics Biotech · Germany | 2005 |
| Od-os MedTech · Germany | 2008 |
Realized
4 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| BRAIN Biotech Biotech · Germany | 2006 | 2016 | IPO | – | – |
| Ganymed Pharmaceuticals Biotech · Germany | 2007 | 2016 | Trade Sale | Astellas Pharma | – |
| Immatics Biotech · Germany | 2010 | 2020 | IPO | Athos | – |
| SuppreMol Biotech · Germany | 2007 | 2015 | Trade Sale | Baxter International | – |
Frequently asked questions
- What investment strategy does MIG Capital focus on?
- MIG Capital focuses on VC, Growth strategies in the private equity space.
- How many portfolio companies does MIG Capital have?
- MIG Capital has 31 active portfolio companies and 12 completed exits and 6 funds tracked on GP Intel.
- Where is MIG Capital headquartered?
- MIG Capital is headquartered in Munich, Germany.
- What is MIG Capital's assets under management?
- MIG Capital manages approximately €1.3B in assets under management.
- When was MIG Capital founded?
- MIG Capital was founded in 2004.
- What sectors does MIG Capital invest in?
- MIG Capital invests across Healthcare, TMT, Industrials, Software, Energy.
- What are MIG Capital's recent exits?
- Recent realized exits by MIG Capital include: German Bionic (2025) to Archimedes Partners; Advanced Medical Balloons (2025) to Stryker; Biocrates (2025) to Bruker Corporation; Cynora (2022) to Samsung Display; Immatics (2020) to ARYA Sciences Acquisition Corp.; Immatics (2020) to Athos; Siltectra (2018) to Infineon Technologies; Ganymed Pharmaceuticals (2016) to Astellas Pharma.
Similar firms
Other private equity firms tracked on GP Intel.